SAN ANTONIO — Remibrutinib displayed sustained efficacy for chronic spontaneous urticaria with a favorable safety profile over 52 weeks, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Treating these patients has a huge, huge impact on the patient’s well-being and quality of life,” Warner W. Carr, MD, FACP, FACAAI,
SAN ANTONIO — Multiple factors may predict whether pediatric patients will be admitted to the hospital for acute asthma exacerbations, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“We aimed to understand the impact of prehospitalization factors such as demographics, socioeconomic status and chronic asthma management parameters
SAN ANTONIO — Multiple factors modulate the relationship between pollen counts and allergic disease, inhibiting preventive care, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Unfortunately, we don’t have a ‘one size fits all’ to predict the effect of pollen levels on disease symptoms,” Reena Yaman, MD,
SAN ANTONIO — Patients with a history of delayed hypersensitivity to iodinated contrast media exhibited a broad cross-reactivity pattern, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.Also, interferon-gamma enzyme-linked ImmunoSpot (ELISpot) assays were inconsistently helpful, possible because of cytotoxicity induced by the iodinated
SAN ANTONIO — Mental health concerns present a burden for patients with food allergies, especially those with multiple food allergies, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Unfortunately, in the folks dealing with multiple food allergies, every single one of their articulated mental health concerns was more likely to be